2 Big Reasons To Hold CSL Shares In 2019
Max Wagner
July 22, 2019
CSL Limited (ASX:CSL) shares sit around 5% below the 52-week
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) shares sit around 5% below the 52-week
The healthcare industry benefits from an ageing population. I look
Founded in the 1890s Ansell Limited (ASX: ANN) is one
The 52-week high price for Cochlear Limited (ASX: COH) shares
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Healthcare giant CSL Limited (ASX:CSL) has outlined the effects of
The ASX 200 (INDEXASX: XJO)(^AXJO) is expected to open lower
The ASX 200 (INDEXASX:XJO)(^AXJO) could be due for a big
CSL Limited (ASX:CSL) shares are a favourite blue-chip for many
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
